Ledger.Open graph →
SEC Form D · filed July 25, 2018

Auron Therapeutics, Inc

Offering
$1.5M
Sold
$660K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WELLESLEY, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Mark Dinner · Dover, DEDirectorRonald D. Dodson · Dallas, TXExec · DirectorRicardo Bekin · Chicago, ILExec · DirectorSteven Glick · Brooklyn, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗